Stryker Corp (BSP:S1YK34)
R$ 103.1 0 (0%) Market Cap: 786.07 Bil Enterprise Value: 848.62 Bil PE Ratio: 39.32 PB Ratio: 6.94 GF Score: 89/100

Stryker Corp at Bank of America Healthcare Conference Transcript

May 11, 2022 / 03:00PM GMT
Release Date Price: R$58.58 (+0.50%)
Travis Lee Steed
BofA Securities, Research Division - MD

Travis Steed, medical device analyst at Bank of America, and glad to have Stryker here this morning. I have Andy Pierce, Group President of MedSurg and NeuroTech. We also have Preston Wells, VP of IR, for about another month. And so Preston, maybe you want to introduce the new IR in transition.

Preston Wells
Stryker Corporation - VP of IR

Absolutely. So Jason Beach, who's down here in the front left, will be assuming the IR responsibilities for Stryker as I transition back into the business.

Travis Lee Steed
BofA Securities, Research Division - MD

Great. And look forward to working with you, Jason.

Questions & Answers

Travis Lee Steed
BofA Securities, Research Division - MD

So I guess, Preston, we could start out on -- we'll start the top line recovery. Strong March, sounds like things were also strong in April as well. Like how are you seeing the top line recovery throughout 2022 and especially the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot